Laura D. Hover
0009-0007-2106-8679
Publication & Citation Trends
Publications
124 total
Adeno-to-squamous transition drives resistance to KRAS inhibition in LKB1 mutant lung cancer PDF
Cited by 105
OpenAlex
The SOS1 Inhibitor MRTX0902 Blocks KRAS Activation and Demonstrates Antitumor Activity in Cancers Dependent on KRAS Nucleotide Loading PDF
Cited by 27
OpenAlex
MRTX1719 Is an MTA-Cooperative PRMT5 Inhibitor That Exhibits Synthetic Lethality in Preclinical Models and Patients with <i>MTAP</i> -Deleted Cancer PDF
Cited by 179
OpenAlex
Patient-derived models recapitulate heterogeneity of molecular signatures and drug response in pediatric high-grade glioma PDF
Cited by 61
OpenAlex
Deep multiomics profiling of brain tumors identifies signaling networks downstream of cancer driver genes PDF
Cited by 79
OpenAlex
Defining Optimal Target Volumes of Conformal Radiation Therapy for Diffuse Intrinsic Pontine Glioma PDF
Cited by 19
OpenAlex
Structure and evolution of double minutes in diagnosis and relapse brain tumors PDF
Cited by 89
OpenAlex
Research Topics
Cancer-related gene regulation
(53)
ATP Synthase and ATPases Research
(17)
Lung Cancer Treatments and Mutations
(15)
Biochemical and Molecular Research
(15)
Glioma Diagnosis and Treatment
(14)
Affiliations
Forest Institute
St. Jude Children's Research Hospital
The University of Texas MD Anderson Cancer Center
Vanderbilt University
Ansys (United States)